House of Lords Business
Show full summary

Lord Mendelsohn to ask Her Majesty's Government how the NHS is monitoring (1) the health of patients who (a) have been denied access to immunoglobulin therapy or (b) are on sub-optimal care in relation to immunoglobulin therapy, and (2) the additional cost of patients (a) not having immunoglobulin treatment or (b) being on sub-optimal treatment.  HL4564

Question HL4564: tabled on 30 November 2021 and due for answer by 14 December 2021

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask Her Majesty's Government how the NHS is monitoring (1) the health of patients who (a) have been denied access to immunoglobulin therapy or (b) are on sub-optimal care in relation to immunoglobulin therapy, and (2) the additional cost of patients (a) not having immunoglobulin treatment or (b) being on sub-optimal treatment.  HL4564
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Mendelsohn
Labour
Life peer